A group:TR

2 trials

Sponsors

The Second Affiliated Hospital of Xingtai Medical College

Conditions

Epidermal growth factor receptor (EGFR) exon 19 deletion mutation or exon 21 L858R substitution mutation locally advanced or metastatic non-small cell lung cancer (NSCLC)For the treatment of adult type 2 diabetes

Phase 1

A randomized, open, two-period, self-cross-control design, using glucose clamp technology to evaluate the pharmacokinetics, pharmacodynamics and safety of insulin degludec injection and

RecruitingChiCTR2100043751

The Second Affiliated Hospital of Xingtai Medical CollegeFor the treatment of adult type 2 diabetes

Start: 2021-03-01Updated: 2021-06-28

Unknown Phase

Pharmacokinetic study of dacomitinib tablets in healthy subjects

RecruitingChiCTR2000038991

The Second Affiliated Hospital of Xingtai Medical CollegeEpidermal growth factor receptor (EGFR) exon 19 deletion mutation or exon 21 L858R substitution mutation locally advanced or metastatic non-small cell lung cancer (NSCLC)

Start: 2020-11-02Updated: 2021-01-11